DÄ internationalArchiveReferences
References

Review article

The Serological Diagnosis of Rheumatoid Arthritis

Dtsch Arztebl Int 2009; 106(10): 159-63. DOI: 10.3238/arztebl.2009.0159

Egerer, K; Feist, E; Burmester, G

1. Dörner T, Egerer K, Feist E, Burmester GR: Rheumatoid factor revisited. Curr Opin Rheumatol 2004; 16: 246–53. MEDLINE
2. Arnett FC, Edworthy SM, Bloch DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24. MEDLINE
3. Schur PH: Anti-cyclic citrullinated peptide antibodies: diagnostic, predictive and monitoring value in RA. Int J Adv Rheumatol 2005; 3: 77–83.
4. Van Venrooij WJ, Pruijn GJ: Citrullination: a small change for a protein with great consequences for rheumatoid arthritis. Arthritis Res 2000; 2: 249–51. MEDLINE
5. Yoiinou P, Serre G: The anti-perinuclear factor and antikeratin antibody systems. Int Arch Allergy Immunol 1995; 107: 508–18. MEDLINE
6. Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ: Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthris-specific autoantibodies. J Clin Invest 1998; 101: 273–81. MEDLINE
7. Schellekens GA, Visser H, de Jong BA et al.: The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43: 155–63. MEDLINE
8. Van Venrooij WJ, Zendman AJ, Pruuijn GJ: Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis. Autoimmun Rev 2006; 6: 37–41. MEDLINE
9. Van Venrooij WJ, Hazes JM, Visser H: Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis. Neth J Med 2002; 60: 383–8. MEDLINE
10. Coenen D, Verschueren P, Westhovens R, Bossuyt X: Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis. Clin Chem 2007; 53: 498–504. MEDLINE
11. Bizzara N, Tonutti E, Tozzoli R, Villalta D: Analytical and diagnostic characteristics of 11 2nd- and 3rd-generation immunoenzymatic methods for the detection of antibodies to citrullinated proteins. Clin Chem 2007; 53: 1527–33. MEDLINE
12. Sebbag M, Moinard N, Auger I et al.: Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins. Eur J Immunol 2006; 36: 2250–63.. MEDLINE
13. Vander Cruyssen B, Cantaert T, Nogueira L et al.: Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays. Arthritis Res Ther 2006; 8: R122. MEDLINE
14. Nielen MM, van der Horst AR, van Schaardenburg D et al.: Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis. Ann Rheum Dis 2005; 64: 1199–204. MEDLINE
15. Kinloch A, Tatzer V, Wait R et al.: Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res Ther 2005; 7: R1421–9. MEDLINE
16. Saulot V, Vittecoq O, Charlionet R et al.: Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis. Arthritis Rheum 2002; 46: 1196–201. MEDLINE
17. Vossenaar ER, Despres N, Lapointe E et al.: Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther 2004; 6: R142–50. MEDLINE
18. Bang H, Egerer K, Gauliard A et al.: Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Arthritis Rheum 2007; 56: 2503–11. MEDLINE
19. Dejaco C, Klotz W, Larcher H, Duftner C, Schirmer M, Herold M: Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis. Arthritis Res Ther 2006; 8: R119. MEDLINE
20. Soós L, Szekanecz Z, Szabo Z et al.: Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis. J Rheumatol 2007; 34: 1658–63. MEDLINE
21. Usum J, Nielen MM, van Schaardenburg et al.: Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study. Arthritis Res Ther 2008; 10: R12. MEDLINE
22. Innala L, Kokkonen H, Eriksson C et al.: Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides. J Rheumatol 2008; 35: 1002–8. MEDLINE
23. Mathsson L, Mullazehi M, Wick MC et al.: Antibodies against citrullinated vimentin in rheumatoid arthritis. Arthritis Rheum 2008; 58: 36–45. MEDLINE
24. Feist E, Egerer K, Burmester GR: Autoantikörperprofile bei der rheumatoiden Arthritis Z Rheumatol 2007; 66: 212–8. MEDLINE
25. Snijders GF, den Broeder AA, Bevers K et al.: Measurement characteristics of a new rapid anti-CCP2 test compared to the anti-CCP2 ELISA. Scand J Rheumatol 2008; 37: 151–4. MEDLINE